Takeda Pharmaceutical Co Ltd ADR Cash Flow-to-Debt Ratio
Takeda Pharmaceutical Co Ltd ADR cash flow-to-debt ratio. Takeda Pharmaceutical Co Ltd ADR (TAK) has a Cash Flow-to-Debt Ratio of 0.05x as of December 2025, meaning its operating cash flow of $360.04 Billion could theoretically repay 0% of its total liabilities ($7.77 Trillion) in one year. Check TAK cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Takeda Pharmaceutical Co Ltd ADR (2001–2025)
Cash flow-to-debt ratio of Takeda Pharmaceutical Co Ltd ADR from 2001 to 2025. Historical debt coverage capacity for Takeda Pharmaceutical Co Ltd ADR across 25 annual periods. Check earnings quality score of Takeda Pharmaceutical Co Ltd ADR to evaluate the quality of earnings relative to operating cash generation.
Takeda Pharmaceutical Co Ltd ADR Cash Flow-to-Debt Ratio by Year (2001–2025)
Takeda Pharmaceutical Co Ltd ADR cash flow-to-debt ratio by year from 2001 to 2025. Year-by-year debt coverage analysis for Takeda Pharmaceutical Co Ltd ADR. For the full cash flow conversion analysis, see TAK cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | $1.06 Trillion | $7.31 Trillion | ▲ +58.1% |
| 2024 | 0.09x | $716.34 Billion | $7.83 Trillion | ▼ -28.9% |
| 2023 | 0.13x | $977.16 Billion | $7.60 Trillion | ▼ -14.2% |
| 2022 | 0.15x | $1.12 Trillion | $7.49 Trillion | ▲ +14.7% |
| 2021 | 0.13x | $1.01 Trillion | $7.74 Trillion | ▲ +57.9% |
| 2020 | 0.08x | $669.75 Billion | $8.09 Trillion | ▲ +119.4% |
| 2019 | 0.04x | $328.48 Billion | $8.71 Trillion | ▼ -79.1% |
| 2018 | 0.18x | $377.85 Billion | $2.09 Trillion | ▲ +66.6% |
| 2017 | 0.11x | $261.36 Billion | $2.41 Trillion | ▲ +672.3% |
| 2016 | 0.01x | $25.49 Billion | $1.81 Trillion | ▼ -83.9% |
| 2015 | 0.09x | $182.52 Billion | $2.09 Trillion | ▲ +19.4% |
| 2014 | 0.07x | $148.34 Billion | $2.03 Trillion | ▼ -58.8% |
| 2013 | 0.18x | $307.71 Billion | $1.73 Trillion | ▼ -20.6% |
| 2012 | 0.22x | $336.57 Billion | $1.51 Trillion | ▼ -55.6% |
| 2011 | 0.50x | $326.94 Billion | $649.75 Billion | ▼ -13.1% |
| 2010 | 0.58x | $381.17 Billion | $658.53 Billion | ▲ +25.3% |
| 2009 | 0.46x | $326.27 Billion | $706.35 Billion | ▼ -16.8% |
| 2008 | 0.56x | $292.50 Billion | $526.75 Billion | ▲ +62.2% |
| 2007 | 0.34x | $209.28 Billion | $611.38 Billion | ▼ -36.4% |
| 2006 | 0.54x | $373.57 Billion | $693.87 Billion | ▼ -0.9% |
| 2005 | 0.54x | $295.54 Billion | $544.02 Billion | ▼ -3.2% |
| 2004 | 0.56x | $311.12 Billion | $554.65 Billion | ▲ +4.7% |
| 2003 | 0.54x | $263.45 Billion | $491.64 Billion | ▲ +12.7% |
| 2002 | 0.48x | $240.59 Billion | $505.88 Billion | ▲ +11.3% |
| 2001 | 0.43x | $212.66 Billion | $497.69 Billion | — |